Repligen Corp. [RGEN] stock prices are up 0.48% to $145.17 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RGEN shares have lost -0.18% over the last week, with a monthly amount drifted -11.35%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Repligen Corp. [NASDAQ: RGEN] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Overweight rating and assigned the stock a price target of $180. Previously, Deutsche Bank upgraded its rating to Buy on June 26, 2024, and dropped its price target to $155. On June 18, 2024, Guggenheim initiated with a Neutral rating. The Benchmark Company downgraded its rating to a Hold. Wells Fargo initiated its recommendation with a Overweight and recommended $185 as its price target on July 20, 2023. In a note dated March 28, 2023, The Benchmark Company initiated an Buy rating and provided a target price of $230 on this stock.
The stock price of Repligen Corp. [RGEN] has been fluctuating between $110.45 and $211.13 over the past year. Currently, Wall Street analysts expect the stock to reach $189.5 within the next 12 months. Repligen Corp. [NASDAQ: RGEN] shares were valued at $145.17 at the most recent close of the market. An investor can expect a potential return of 30.54% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
The Repligen Corp. [NASDAQ:RGEN] reported sales of 602.35M for trailing twelve months, representing a drop of -3.20%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.0 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 142.78 points at the first support level, and at 140.39 for the second support level. However, for the 1st resistance point, the stock is sitting at 146.90, and for the 2nd resistance point, it is at 148.63.
Ratios To Look Out For
It’s worth pointing out that Repligen Corp. [NASDAQ:RGEN]’s Current Ratio is 6.65. Further, the Quick Ratio stands at 5.56, while the Cash Ratio is 4.64. Considering the valuation of this stock, the price to sales ratio is 13.50, the price to book ratio is 4.09.
Transactions by insiders
Recent insider trading involved KURIYEL RALF, Senior VP, R&D, that happened on Aug 02 ’24 when 7148.0 shares were sold. Senior Vice President, Ralf Kuriyel completed a deal on Aug 02 ’24 to buy 7148.0 shares. Meanwhile, Senior VP, R&D KURIYEL RALF sold 4465.0 shares on Aug 01 ’24.
